Oregon Pacific Wealth Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,717
Closed -$237K 124
2025
Q4
$237K Sell
1,717
-51
-3% -$6.68K 0.24% 101
2025
Q3
$227K Sell
1,768
-45
-2% -$5.49K 0.2% 120
2025
Q2
$219K Sell
1,813
-30
-2% -$3.38K 0.21% 119
2025
Q1
$205K Buy
+1,843
New +$196K 0.21% 123

Other funds holding NVS

Oregon Pacific Wealth Management's NVS Position: Q1 2026 in Review

Oregon Pacific Wealth Management sold out of Novartis (NVS) in Q1 2026, closing a stake of 1,717 shares — an estimated $237K sold.

Oregon Pacific Wealth Management first reported a position in NVS in Q1 2025 and held it in 4 quarters. The position peaked at $237K in Q4 2025. 1,591 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

  • Oregon Pacific Wealth Management reported no remaining Novartis position as of Q1 2026 after selling out during the quarter.
  • Oregon Pacific Wealth Management sold 1,717 Novartis shares in Q1 2026, an estimated $237K.
  • Oregon Pacific Wealth Management first reported a position in Novartis in Q1 2025 and held it in 4 quarters.
  • Oregon Pacific Wealth Management's Novartis position peaked at $237K in Q4 2025.
  • 1,591 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on Oregon Pacific Wealth Management's 13F filing for Q1 2026, filed 23 Apr 2026.